The groundbreaking therapy of this peptide represents a exciting development in the management of type 2 diabetes. Unlike existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide757805.dm-blog.com/42361559/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment